TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

MSN PHARMS INC

Neurology
Generics

MSN PHARMS INC is a generic drug manufacturer focused on Neurology.

2021
Since
3
Drugs
-
Trials
3
Approved (2yr)

Key Drugs

No active drugs

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 100%
1 drugs

Pipeline Strength Pro

Loading...